555 research outputs found
Π‘Π ΠΠΠΠΠ’ΠΠΠ¬ΠΠ«Π ΠΠΠΠΠΠ ΠΠΠΠΠ‘ΠΠ ΠΠΠΠ’ΠΠ ΠΠ‘Π’Π ΠΠΠΠ-Π ΠΠΠΠ‘Π’ΠΠΠ’ΠΠΠΠ Π ΠΠΠ ΠΠΠΠΠ§ΠΠΠ ΠΠΠΠΠΠ«
The exosomes involvement in the pathogenesis of tumors is based on their property to incorporate into theΒ recipient cells resulting in the both genomic and epigenomic changes.Β Earlier we have shown that exosomesΒ from different types of estrogen-independent breastΒ cancer cells (MCF-7/T developed by long-term tamoxifenΒ treatment, and MCF-7/M)Β developed by metformin treatment were able to transfer resistance to the parentΒ MCF-7Β cells. To elucidate the common features of the both types of resistant exosomes, theΒ proteome andΒ microRNA cargo of the control and both types of the resistant exosomes wereΒ analyzed. Totally, more thanΒ 400 proteins were identified in the exosome samples. Of theseΒ proteins, only two proteins, DMBT1 (Deleted inΒ Malignant Brain Tumors 1) and THBS1Β (Thrombospondin-1), were commonly expressed in the both resistantΒ exosomes (less thanΒ 5% from total DEPs) demonstrating the unique protein composition of each type of theΒ resistant exosomes. The comparative analysis of the miRNA differentially expressed inΒ the both MCF-7/T andΒ MCF-7/M resistant exosomes revealed 180 up-regulated and 202Β down-regulated miRNAs. Among them,Β 4 up-regulated and 8 down-regulated miRNAs wereΒ associated with progression of hormonal resistance ofΒ breast tumors. The bioinformaticalΒ analysis of 4 up-regulated exosomal miRNAs revealed 2 miRNAs, mir-Β 101and mir-181b, which up-regulated PI3K signalingΒ supporting the key role of PI3K/Akt in the developmentΒ of the resistant phenotype of breast cancer cells.Π£ΡΠ°ΡΡΠΈΠ΅ ΡΠΊΠ·ΠΎΡΠΎΠΌ Π² ΠΏΠ°ΡΠΎΠ³Π΅Π½Π΅Π·Π΅ Π·Π»ΠΎΠΊΠ°ΡΠ΅ΡΡΠ²Π΅Π½Π½ΡΡ
ΠΎΠΏΡΡ
ΠΎΠ»Π΅ΠΉ ΠΎΡΠ½ΠΎΠ²Π°Π½ΠΎ Π½Π° ΠΈΡ
ΡΠΏΠΎΡΠΎΠ±Π½ΠΎΡΡΠΈ ΠΏΡΠΎΠ½ΠΈΠΊΠ°ΡΡ Π²Π½ΡΡΡΡΒ ΠΊΠ»Π΅ΡΠΎΠΊ-ΡΠ΅ΡΠΈΠΏΠΈΠ΅Π½ΡΠΎΠ², Π²ΡΠ·ΡΠ²Π°Ρ Π² ΠΏΠΎΡΠ»Π΅Π΄Π½ΠΈΡ
ΠΊΠ°ΡΠΊΠ°Π΄ Π³Π΅Π½Π΅ΡΠΈΡΠ΅ΡΠΊΠΈΡ
ΠΈ ΡΠΏΠΈΠ³Π΅Π½Π΅ΡΠΈΡΠ΅ΡΠΊΠΈΡ
ΠΈΠ·ΠΌΠ΅Π½Π΅Π½ΠΈΠΉ. Π Π°Π½Π΅Π΅Β ΠΌΡΒ ΠΏΠΎΠΊΠ°Π·Π°Π»ΠΈ, ΡΡΠΎ ΡΠΊΠ·ΠΎΡΠΎΠΌΡ, ΠΏΡΠΎΠ΄ΡΡΠΈΡΡΠ΅ΠΌΡΠ΅ ΡΠ°Π·Π»ΠΈΡΠ½ΡΠΌΠΈ Π²Π°ΡΠΈΠ°Π½ΡΠ°ΠΌΠΈ ΡΡΡΡΠΎΠ³Π΅Π½-Π½Π΅Π·Π°Π²ΠΈΡΠΈΠΌΡΡ
ΡΡΠ±Π»ΠΈΠ½ΠΈΠΉΒ ΠΊΠ»Π΅ΡΠΎΠΊΒ ΡΠ°ΠΊΠ° ΠΌΠΎΠ»ΠΎΡΠ½ΠΎΠΉ ΠΆΠ΅Π»Π΅Π·Ρ (MCF-7/T, ΠΏΠΎΠ»ΡΡΠ΅Π½Π½ΠΎΠΉ Π² ΡΠ΅Π·ΡΠ»ΡΡΠ°ΡΠ΅ Π΄Π»ΠΈΡΠ΅Π»ΡΠ½ΠΎΠ³ΠΎ ΠΊΡΠ»ΡΡΠΈΠ²ΠΈΡΠΎΠ²Π°Π½ΠΈΡ ΠΊΠ»Π΅ΡΠΎΠΊΒ Π²Β ΠΏΡΠΈΡΡΡΡΡΠ²ΠΈΠΈ Π°Π½ΡΠΈΡΡΡΡΠΎΠ³Π΅Π½Π° ΡΠ°ΠΌΠΎΠΊΡΠΈΡΠ΅Π½Π°, ΠΈ MCF-7/M, ΠΏΠΎΠ»ΡΡΠ΅Π½Π½ΠΎΠΉ Π² ΡΠ΅Π·ΡΠ»ΡΡΠ°ΡΠ΅ ΠΊΡΠ»ΡΡΠΈΠ²ΠΈΡΠΎΠ²Π°Π½ΠΈΡΒ ΠΊΠ»Π΅ΡΠΎΠΊ ΡΒ ΠΌΠ΅ΡΡΠΎΡΠΌΠΈΠ½ΠΎΠΌ), ΡΠΏΠΎΡΠΎΠ±Π½Ρ ΠΈΠ½Π΄ΡΡΠΈΡΠΎΠ²Π°ΡΡ ΡΠ΅Π·ΠΈΡΡΠ΅Π½ΡΠ½ΠΎΡΡΡ Π² ΡΠΎΠ΄ΠΈΡΠ΅Π»ΡΡΠΊΠΈΡ
ΠΊΠ»Π΅ΡΠΊΠ°Ρ
MCF-7.Β Π Π½Π°ΡΡΠΎΡΡΠ΅ΠΉ ΡΠ°Π±ΠΎΡΠ΅Β Π΄Π»Ρ ΠΈΡΡΠ»Π΅Π΄ΠΎΠ²Π°Π½ΠΈΡ Ρ
Π°ΡΠ°ΠΊΡΠ΅ΡΠ½ΡΡ
ΠΎΡΠΎΠ±Π΅Π½Π½ΠΎΡΡΠ΅ΠΉ ΡΠΎΡΡΠ°Π²Π° ΡΠΊΠ·ΠΎΡΠΎΠΌ ΡΠ΅Π·ΠΈΡΡΠ΅Π½ΡΠ½ΡΡ
Β ΠΊΠ»Π΅ΡΠΎΠΊ Π±ΡΠ» ΠΏΡΠΎΠ²Π΅Π΄Π΅Π½Β ΡΡΠ°Π²Π½ΠΈΡΠ΅Π»ΡΠ½ΡΠΉ Π°Π½Π°Π»ΠΈΠ· ΠΏΡΠΎΡΠ΅ΠΎΠΌΠ° ΠΈ ΠΏΡΠΎΡΠΈΠ»Ρ ΠΌΠΈΠΊΡΠΎΠ ΠΠ ΠΊΠΎΠ½ΡΡΠΎΠ»ΡΠ½ΡΡ
ΡΠΊΠ·ΠΎΡΠΎΠΌ ΠΈΒ ΡΠΊΠ·ΠΎΡΠΎΠΌ, ΠΏΠΎΠ»ΡΡΠ΅Π½Π½ΡΡ
ΠΎΡΒ ΡΠ΅Π·ΠΈΡΡΠ΅Π½ΡΠ½ΡΡ
ΡΡΠ±Π»ΠΈΠ½ΠΈΠΉ. Π ΡΠ΅Π»ΠΎΠΌ Π² ΠΎΠ±ΡΠ°Π·ΡΠ°Ρ
ΡΠΊΠ·ΠΎΡΠΎΠΌ Π±ΡΠ»ΠΎ ΠΈΠ΄Π΅Π½ΡΠΈΡΠΈΡΠΈΡΠΎΠ²Π°Π½ΠΎΒ Π±ΠΎΠ»Π΅Π΅ 400 Π±Π΅Π»ΠΊΠΎΠ², ΠΈΠ· ΠΊΠΎΡΠΎΡΡΡ
Β ΡΠΎΠ»ΡΠΊΠΎ 2 Π±Π΅Π»ΠΊΠ°, DMBT1 (Deleted in Malignant Brain Tumors 1) ΠΈ THBS1Β (Thrombospondin-1), Π±ΡΠ»ΠΈΒ Π³ΠΈΠΏΠ΅ΡΡΠΊΡΠΏΡΠ΅ΡΡΠΈΡΠΎΠ²Π°Π½Ρ Π² ΠΎΠ±ΠΎΠΈΡ
ΡΠΈΠΏΠ°Ρ
ΡΠ΅Π·ΠΈΡΡΠ΅Π½ΡΠ½ΡΡ
ΡΠΊΠ·ΠΎΡΠΎΠΌ (ΠΌΠ΅Π½Π΅Π΅ 5 % ΠΎΡΒ ΠΎΠ±ΡΠ΅Π³ΠΎ ΠΊΠΎΠ»ΠΈΡΠ΅ΡΡΠ²Π° Π±Π΅Π»ΠΊΠΎΠ²,Β Π΄ΠΈΡΡΠ΅ΡΠ΅Π½ΡΠΈΠ°Π»ΡΠ½ΠΎ ΡΠΊΡΠΏΡΠ΅ΡΡΠΈΡΠΎΠ²Π°Π½Π½ΡΡ
Π² ΡΠΊΠ·ΠΎΡΠΎΠΌΠ°Ρ
ΡΠ΅Π·ΠΈΡΡΠ΅ΡΠ½ΡΡ
ΠΊΠ»Π΅ΡΠΎΠΊ), ΡΡΠΎΒ ΡΠ²ΠΈΠ΄Π΅ΡΠ΅Π»ΡΡΡΠ²ΡΠ΅Ρ ΠΎΠ± ΡΠ½ΠΈΠΊΠ°Π»ΡΠ½ΠΎΠΌΒ ΡΠΎΡΡΠ°Π²Π΅ ΡΠΊΠ·ΠΎΡΠΎΠΌΠ°Π»ΡΠ½ΡΡ
Π±Π΅Π»ΠΊΠΎΠ² Π΄Π»Ρ ΠΊΠ°ΠΆΠ΄ΠΎΠ³ΠΎ ΡΠΈΠΏΠ° ΡΠ΅Π·ΠΈΡΡΠ΅Π½ΡΠ½ΡΡ
ΠΊΠ»Π΅ΡΠΎΠΊ.Β Π‘ΡΠ°Π²Π½ΠΈΡΠ΅Π»ΡΠ½ΡΠΉ Π°Π½Π°Π»ΠΈΠ·Β ΡΠΎΡΡΠ°Π²Π° ΠΌΠΈΠΊΡΠΎΠ ΠΠ, Π΄ΠΈΡΡΠ΅ΡΠ΅Π½ΡΠΈΠ°Π»ΡΠ½ΠΎ ΡΠΊΡΠΏΡΠ΅ΡΡΠΈΡΠΎΠ²Π°Π½Π½ΡΡ
Π² ΠΎΠ±ΠΎΠΈΡ
Π²Π°ΡΠΈΠ°Π½ΡΠ°Ρ
Β ΡΠΊΠ·ΠΎΡΠΎΠΌ ΡΠ΅Π·ΠΈΡΡΠ΅Π½ΡΠ½ΡΡ
ΠΊΠ»Π΅ΡΠΎΠΊ,Β Π²ΡΡΠ²ΠΈΠ» 180 Π³ΠΈΠΏΠ΅ΡΡΠΊΡΠΏΡΠ΅ΡΡΠΈΡΠΎΠ²Π°Π½Π½ΡΡ
ΠΌΠΈΠΊΡΠΎΠ ΠΠ ΠΈ 202 ΠΌΠΈΠΊΡΠΎΠ ΠΠ Ρ ΠΏΠΎΠ½ΠΈΠΆΠ΅Π½Π½ΠΎΠΉ ΡΠΊΡΠΏΡΠ΅ΡΡΠΈΠ΅ΠΉ. Π‘ΡΠ΅Π΄ΠΈ Π½ΠΈΡ
4Β Π³ΠΈΠΏΠ΅ΡΡΠΊΡΠΏΡΠ΅ΡΡΠΈΡΠΎΠ²Π°Π½Π½ΡΡ
ΠΈ 8 Π³ΠΈΠΏΠΎΡΠΊΡΠΏΡΠ΅ΡΡΠΈΡΠΎΠ²Π°Π½Π½ΡΡ
ΠΌΠΈΠΊΡΠΎΠ ΠΠΒ ΠΎΠΊΠ°Π·Π°Π»ΠΈΡΡ Π°ΡΡΠΎΡΠΈΠΈΡΠΎΠ²Π°Π½Ρ Ρ ΡΠ°Π·Π²ΠΈΡΠΈΠ΅ΠΌΒ Π³ΠΎΡΠΌΠΎΠ½Π°Π»ΡΠ½ΠΎΠΉ ΡΠ΅Π·ΠΈΡΡΠ΅Π½ΡΠ½ΠΎΡΡΠΈ ΠΊΠ»Π΅ΡΠΎΠΊ ΡΠ°ΠΊΠ° ΠΌΠΎΠ»ΠΎΡΠ½ΠΎΠΉ ΠΆΠ΅Π»Π΅Π·Ρ.Β ΠΠΈΠΎΠΈΠ½ΡΠΎΡΠΌΠ°ΡΠΈΡΠ΅ΡΠΊΠΈΠΉ Π°Π½Π°Π»ΠΈΠ· 4Β Π³ΠΈΠΏΠ΅ΡΡΠΊΡΠΏΡΠ΅ΡΡΠΈΡΠΎΠ²Π°Π½Π½ΡΡ
ΠΌΠΈΠΊΡΠΎΠ ΠΠ Π²ΡΡΠ²ΠΈΠ» 2 ΠΌΠΈΠΊΡΠΎΠ ΠΠ, mir-101ΠΈΒ mir-181b, ΡΡΠ°ΡΡΠ²ΡΡΡΠΈΡ
Π² ΡΡΠΈΠΌΡΠ»ΡΡΠΈΠΈ PI3KΒ ΡΠΈΠ³Π½Π°Π»ΠΈΠ½Π³Π°, ΡΠ²ΠΈΠ΄Π΅ΡΠ΅Π»ΡΡΡΠ²ΡΡ ΠΎ Π²Π°ΠΆΠ½ΠΎΠΉ ΡΠΎΠ»ΠΈ ΠΏΠΎΡΠ»Π΅Π΄Π½Π΅Π³ΠΎ Π²Β ΡΠ°Π·Π²ΠΈΡΠΈΠΈ Π³ΠΎΡΠΌΠΎΠ½Π°Π»ΡΠ½ΠΎΠΉ ΡΠ΅Π·ΠΈΡΡΠ΅Π½ΡΠ½ΠΎΡΡΠΈΒ ΠΊΠ»Π΅ΡΠΎΠΊ ΡΠ°ΠΊΠ° ΠΌΠΎΠ»ΠΎΡΠ½ΠΎΠΉ ΠΆΠ΅Π»Π΅Π·Ρ.
Are mild head injuries as mild as we think? Neurobehavioral concomitants of chronic post-concussion syndrome
BACKGROUND: Mild traumatic brain injury (MTBI) can sometimes lead to persistent postconcussion symptoms. One well accepted hypothesis claims that chronic PCS has a neural origin, and is related to neurobehavioral deficits. But the evidence is not conclusive. In the attempt to characterise chronic MTBI consequences, the present experiment used a group comparison design, which contrasted persons (a) with MTBI and PCS, (b) MTBI without PCS, and (c) matched controls. We predicted that participants who have experienced MTBI but show no signs of PCS would perform similar to controls. At the same time, a subgroup of MTBI participants would show PCS symptoms and only these volunteers would have poorer cognitive performance. Thereby, the performance deficits should be most noticeable in participants with highest PCS severity. METHOD: 38 patients with a single MTBI that had occurred at least 12 month prior to testing, and 38 matched controls, participated in the experiment. A combination of questionnaires and neuropsychological test batteries were used to assess the extent of PCS and related deficits in neurobehavioral performance. RESULTS: 11 out of 38 MTBI participants (29%) were found to suffer from PCS. This subgroup of MTBI patients performed poorly on neuropsychological test batteries. Thereby, a correlation was found between PCS symptom severity and test performance suggesting that participants with more pronounced PCS symptoms performed worse in cognitive tasks. In contrast, MTBI patients with no PCS showed performed similar to matched control. We further found that loss of consciousness, a key criterion for PCS diagnosis, was not predictive of sustained PCS. CONCLUSION: The results support the idea that MTBI can have sustained consequences, and that the subjectively experienced symptoms and difficulties in everyday situations are related to objectively measurable parameters in neurocognitive function
Impaired executive function in male MDMA ("ecsatsy") users.
Rationale: Long-term users of ecstasy have shown impaired performance on a multitude of cognitive abilities (most notably memory, attention, executive function). Research into the pattern of MDMA effects on executive functions remains fragmented, however. Objectives: To determine more systematically what aspects of executive function are affected by a history of MDMA use, by using a model that divides executive functions into cognitive flexibility, information updating and monitoring, and inhibition of pre-potent responses. Methods: MDMA users and controls who abstained from ecstasy and other substances for at least 2 weeks were tested with a computerized cognitive test battery to assess their abilities on tasks that measure the three submodalities of executive function, and their combined contribution on two more complex executive tasks. Because of sex-differential effects of MDMA reported in the literature, data from males and females were analyzed separately. Results: Male MDMA users performed significantly worse on the tasks that tap on cognitive flexibility and on the combined executive function tasks; no differences were found on the other cognitive tasks. Female users showed no impairments on any of the tasks. Conclusions: The present data suggest that a history of MDMA use selectively impairs executive function. In male users, cognitive flexibility was impaired and increased perseverative behavior was observed. The inability to adjust behavior rapidly and flexibly may have repercussions for daily life activities
Detecting coached feigning using the test of Memory Malingering (TOMM) and the structured inventory of Malingered Symptomatology (SIMS)
ΠΠΊΠ·ΠΎΡΠΎΠΌΡ ΠΈ ΡΠ°Π·Π²ΠΈΡΠΈΠ΅ ΡΠ΅Π·ΠΈΡΡΠ΅Π½ΡΠ½ΠΎΡΡΠΈ ΠΎΠΏΡΡ ΠΎΠ»Π΅Π²ΡΡ ΠΊΠ»Π΅ΡΠΎΠΊ ΠΊ ΠΌΠ΅ΡΡΠΎΡΠΌΠΈΠ½Ρ: ΠΏΠΈΠ»ΠΎΡΠ½ΠΎΠ΅ ΠΈΡΡΠ»Π΅Π΄ΠΎΠ²Π°Π½ΠΈΠ΅
Objective: to study the role of the intercellular interactions in the progression of the cancer cells resistance to metformin, a biguanide antidiabetic drug exhibited the marked anti-tumor activity.Results. Earlier we have demonstrated the effect of horizontal transferring of hormonal resistance of breast cancer cellsΒ from cell to cell, and showed the key role of exosomes on the transferring of the resistance. Here we have shown the effect of the horizontal transferring of metformin resistance in breast cancer cells β similar to the progression of hormonal resistance. We found that horizontal transferring of the metformin resistance is mediated via exosomes secreted by the resistant cells. The proteome analysis of the exosomes revealed several proteins differentially expressed in the exosomes of metformin-resistant cells and associated with the regulation of cell response to apoptotic drugs.Conclusions. Totally, the data presented demonstrate the new mechanism of the development of the cancer cell resistance based on the intercellular interactions, opening the new insights in the target therapy of breast cancer.Π¦Π΅Π»Ρ ΡΠ°Π±ΠΎΡΡ β ΠΈΡΡΠ»Π΅Π΄ΠΎΠ²Π°Π½ΠΈΠ΅ ΡΠΎΠ»ΠΈ ΠΌΠ΅ΠΆΠΊΠ»Π΅ΡΠΎΡΠ½ΡΡ
Π²Π·Π°ΠΈΠΌΠΎΠ΄Π΅ΠΉΡΡΠ²ΠΈΠΉ Π² ΡΠ°Π·Π²ΠΈΡΠΈΠΈ ΡΠ΅Π·ΠΈΡΡΠ΅Π½ΡΠ½ΠΎΡΡΠΈ ΠΊΠ»Π΅ΡΠΎΠΊ ΡΠ°ΠΊΠ° ΠΌΠΎΠ»ΠΎΡΠ½ΠΎΠΉ ΠΆΠ΅Π»Π΅Π·Ρ ΠΊ ΠΌΠ΅ΡΡΠΎΡΠΌΠΈΠ½Ρ β Π°Π½ΡΠΈΠ΄ΠΈΠ°Π±Π΅ΡΠΈΡΠ΅ΡΠΊΠΎΠΌΡ ΠΏΡΠ΅ΠΏΠ°ΡΠ°ΡΡ ΠΈΠ· Π³ΡΡΠΏΠΏΡ Π±ΠΈΠ³ΡΠ°Π½ΠΈΠ΄ΠΎΠ², ΠΎΠ±Π»Π°Π΄Π°ΡΡΠ΅ΠΌΡ Π²ΡΡΠ°ΠΆΠ΅Π½Π½ΡΠΌ ΠΏΡΠΎΡΠΈΠ²ΠΎΠΎΠΏΡΡ
ΠΎΠ»Π΅Π²ΡΠΌ ΡΡΡΠ΅ΠΊΡΠΎΠΌ.Π Π΅Π·ΡΠ»ΡΡΠ°ΡΡ. Π ΠΎΡΠ½ΠΎΠ²Ρ ΡΠ°Π±ΠΎΡΡ Π»Π΅Π³Π»ΠΈ Π΄Π°Π½Π½ΡΠ΅, ΠΏΠΎΠ»ΡΡΠ΅Π½Π½ΡΠ΅ Π½Π°ΠΌΠΈ ΡΠ°Π½Π΅Π΅ ΠΏΡΠΈ ΠΈΠ·ΡΡΠ΅Π½ΠΈΠΈ Π³ΠΎΡΠΌΠΎΠ½Π°Π»ΡΠ½ΠΎΠΉ ΡΠ΅Π·ΠΈΡΡΠ΅Π½ΡΠ½ΠΎΡΡΠΈ ΠΊΠ»Π΅ΡΠΎΠΊ ΡΠ°ΠΊΠ° ΠΌΠΎΠ»ΠΎΡΠ½ΠΎΠΉ ΠΆΠ΅Π»Π΅Π·Ρ ΠΈ ΠΏΡΠΎΠ΄Π΅ΠΌΠΎΠ½ΡΡΡΠΈΡΠΎΠ²Π°Π²ΡΠΈΠ΅ Π²ΠΎΠ·ΠΌΠΎΠΆΠ½ΠΎΡΡΡ ΠΏΠ΅ΡΠ΅Π΄Π°ΡΠΈ ΡΠ΅Π·ΠΈΡΡΠ΅Π½ΡΠ½ΠΎΠ³ΠΎ ΡΠ΅Π½ΠΎΡΠΈΠΏΠ° Π³ΠΎΡΠΈΠ·ΠΎΠ½ΡΠ°Π»ΡΠ½ΡΠΌ ΠΏΡΡΠ΅ΠΌ, ΠΎΡ ΠΊΠ»Π΅ΡΠΊΠΈ ΠΊ ΠΊΠ»Π΅ΡΠΊΠ΅, Π² ΡΠΎΠΌ ΡΠΈΡΠ»Π΅ Ρ ΡΡΠ°ΡΡΠΈΠ΅ΠΌ ΡΠΊΠ·ΠΎΡΠΎΠΌ. Π Π½Π°ΡΡΠΎΡΡΠ΅ΠΉ ΡΠ°Π±ΠΎΡΠ΅ ΠΌΡ ΠΏΠΎΠΊΠ°Π·Π°Π»ΠΈ Π²ΠΎΠ·ΠΌΠΎΠΆΠ½ΠΎΡΡΡ ΡΠ°Π·Π²ΠΈΡΠΈΡ ΡΡΡΠΎΠΉΡΠΈΠ²ΠΎΡΡΠΈ ΠΊ ΠΌΠ΅ΡΡΠΎΡΠΌΠΈΠ½Ρ Π³ΠΎΡΠΈΠ·ΠΎΠ½ΡΠ°Π»ΡΠ½ΡΠΌ ΠΏΡΡΠ΅ΠΌ, ΠΊΠ°ΠΊ ΠΈ Π² ΡΠ»ΡΡΠ°Π΅ Π³ΠΎΡΠΌΠΎΠ½Π°Π»ΡΠ½ΠΎΠΉ ΡΠ΅Π·ΠΈΡΡΠ΅Π½ΡΠ½ΠΎΡΡΠΈ. Π£ΡΡΠ°Π½ΠΎΠ²Π»Π΅Π½ΠΎ, ΡΡΠΎ ΡΠ΅ΡΠ°ΡΡΠΈΠΌ ΡΠ°ΠΊΡΠΎΡΠΎΠΌ Π² ΠΏΠΎΠ΄ΠΎΠ±Π½ΠΎΠΌ Π³ΠΎΡΠΈΠ·ΠΎΠ½ΡΠ°Π»ΡΠ½ΠΎΠΌ ΠΏΡΡΠΈ ΠΏΠ΅ΡΠ΅Π΄Π°ΡΠΈ ΡΠ΅Π·ΠΈΡΡΠ΅Π½ΡΠ½ΠΎΡΡΠΈ ΡΠ²Π»ΡΡΡΡΡ ΠΌΠ΅ΠΆΠΊΠ»Π΅ΡΠΎΡΠ½ΡΠ΅ Π²Π·Π°ΠΈΠΌΠΎΠ΄Π΅ΠΉΡΡΠ²ΠΈΡ, ΡΠ΅Π°Π»ΠΈΠ·ΡΠ΅ΠΌΡΠ΅ Π² ΡΠΎΠΌ ΡΠΈΡΠ»Π΅ Ρ ΡΡΠ°ΡΡΠΈΠ΅ΠΌ ΡΠΊΠ·ΠΎΡΠΎΠΌ, ΠΏΡΠΎΠ΄ΡΡΠΈΡΡΠ΅ΠΌΡΡ
ΠΌΠ΅ΡΡΠΎΡΠΌΠΈΠ½ΡΠ΅Π·ΠΈΡΡΠ΅Π½ΡΠ½ΡΠΌΠΈ ΠΊΠ»Π΅ΡΠΊΠ°ΠΌΠΈ. ΠΠ½Π°Π»ΠΈΠ· ΠΏΡΠΎΡΠ΅ΠΎΠΌΠ° ΡΠΊΠ·ΠΎΡΠΎΠΌ ΠΏΠΎΠ΄ΡΠ²Π΅ΡΠ΄ΠΈΠ» ΠΏΡΠΈΡΡΡΡΡΠ²ΠΈΠ΅ Π² ΡΠΊΠ·ΠΎΡΠΎΠΌΠ°Ρ
ΡΠ΅Π·ΠΈΡΡΠ΅Π½ΡΠ½ΡΡ
ΠΊΠ»Π΅ΡΠΎΠΊ Π±Π΅Π»ΠΊΠΎΠ², ΡΠ΅Π³ΡΠ»ΠΈΡΡΡΡΠΈΡ
ΠΎΡΠ²Π΅Ρ ΠΊΠ»Π΅ΡΠΎΠΊ Π½Π° Π΄Π΅ΠΉΡΡΠ²ΠΈΠ΅ Π°ΠΏΠΎΠΏΡΠΎΡΠΈΡΠ΅ΡΠΊΠΈΡ
Π°Π³Π΅Π½ΡΠΎΠ².ΠΠ°ΠΊΠ»ΡΡΠ΅Π½ΠΈΠ΅. ΠΠΎΠ»ΡΡΠ΅Π½Π½ΡΠ΅ Π΄Π°Π½Π½ΡΠ΅ ΠΏΠΎΠ΄ΡΠ²Π΅ΡΠΆΠ΄Π°ΡΡ ΡΡΡΠ΅ΡΡΠ²ΠΎΠ²Π°Π½ΠΈΠ΅ Π½Π΅ΠΈΠ·Π²Π΅ΡΡΠ½ΠΎΠ³ΠΎ ΡΠ°Π½Π΅Π΅ ΠΌΠ΅Ρ
Π°Π½ΠΈΠ·ΠΌΠ° ΡΠ°ΡΠΏΡΠΎΡΡΡΠ°Π½Π΅Π½ΠΈΡ ΡΠ΅Π·ΠΈΡΡΠ΅Π½ΡΠ½ΠΎΡΡΠΈ, ΠΎΡΠ½ΠΎΠ²Π°Π½Π½ΠΎΠ³ΠΎ Π½Π° ΠΌΠ΅ΠΆΠΊΠ»Π΅ΡΠΎΡΠ½ΡΡ
Π²Π·Π°ΠΈΠΌΠΎΠ΄Π΅ΠΉΡΡΠ²ΠΈΡΡ
, ΠΈ ΠΎΡΠΊΡΡΠ²Π°ΡΡ Π½ΠΎΠ²ΡΠ΅ Π²ΠΎΠ·ΠΌΠΎΠΆΠ½ΠΎΡΡΠΈ Π² ΠΏΠΎΠΈΡΠΊΠ΅ ΠΌΠΈΡΠ΅Π½Π΅ΠΉ ΠΏΡΠΎΡΠΈΠ²ΠΎΠΎΠΏΡΡ
ΠΎΠ»Π΅Π²ΠΎΠΉ ΡΠ΅ΡΠ°ΠΏΠΈΠΈ
Magnetic resonance imaging after most common form of concussion
<p>Abstract</p> <p>Background</p> <p>Until now there is a lack of carefully controlled studies with conventional MR imaging performed exclusively in concussion with short lasting loss of consciousness (LOC).</p> <p>Methods</p> <p>A MR investigation was performed within 24 hours and after 3 months in 20 patients who had suffered a concussion with a verified loss of consciousness of maximally 5 minutes. As a control group, 20 age- and gender matched patients with minor orthopaedic injuries had a MR investigation using the same protocol.</p> <p>Results</p> <p>In a concussion population with an average LOC duration of 1. 4 minutes no case with unequivocal intracranial traumatic pathology was detected.</p> <p>Conclusion</p> <p>An ordinary concussion with short lasting LOC does not or only seldom result in a degree of diffuse axonal injury (DAI) that is visualized by conventional MR with field strength of 1.0 Tesla (T). Analysis of earlier MR studies in concussion using field strength of 1.5 T as well as of studies with diffusion tensor MR imaging (MR DTI) reveal methodological shortcomings, in particular use of inadequate control groups. There is, therefore, a need for carefully controlled studies using MR of higher field strength and/or studies with MR DTI exclusively in common concussion with LOC of maximally 5 minutes.</p
Traumatic-event headaches
BACKGROUND: Chronic headaches from head trauma and whiplash injury are well-known and common, but chronic headaches from other sorts of physical traumas are not recognized. METHODS: Specific information was obtained from the medical records of 15 consecutive patients with chronic headaches related to physically injurious traumatic events that did not include either head trauma or whiplash injury. The events and the physical injuries produced by them were noted. The headaches' development, characteristics, duration, frequency, and accompaniments were recorded, as were the patients' use of pain-alleviative drugs. From this latter information, the headaches were classified by the diagnostic criteria of the International Headache Society as though they were naturally-occurring headaches. The presence of other post-traumatic symptoms and litigation were also recorded. RESULTS: The intervals between the events and the onset of the headaches resembled those between head traumas or whiplash injuries and their subsequent headaches. The headaches themselves were, as a group, similar to those after head trauma and whiplash injury. Thirteen of the patients had chronic tension-type headache, two had migraine. The sustained bodily injuries were trivial or unidentifiable in nine patients. Fabrication of symptoms for financial remuneration was not evident in these patients of whom seven were not even seeking payments of any kind. CONCLUSIONS: This study suggests that these hitherto unrecognized post-traumatic headaches constitute a class of headaches characterized by a relation to traumatic events affecting the body but not including head or whiplash traumas. The bodily injuries per se can be discounted as the cause of the headaches. So can fabrication of symptoms for financial remuneration. Altered mental states, not systematically evaluated here, were a possible cause of the headaches. The overall resemblance of these headaches to the headaches after head or whiplash traumas implies that these latter two headache types may likewise not be products of structural injuries
Oculo-visual changes and clinical considerations affecting older patients with dementia
Purpose: Dementia is associated with various alterations of the eye and visual function. Over 60% of cases are attributable to Alzheimer's disease, a significant proportion of the remainder to vascular dementia or dementia with Lewy bodies, while frontotemporal dementia, and Parkinson's disease dementia are less common. This review describes the oculo-visual problems of these five dementias and the pathological changes which may explain these symptoms. It further discusses clinical considerations to help the clinician care for older patients affected by dementia. Recent findings: Visual problems in dementia include loss of visual acuity, defects in colour vision and visual masking tests, changes in pupillary response to mydriatics, defects in fixation and smooth and saccadic eye movements, changes in contrast sensitivity function and visual evoked potentials, and disturbance of complex visual functions such as in reading ability, visuospatial function, and the naming and identification of objects. Pathological changes have also been reported affecting the crystalline lens, retina, optic nerve, and visual cortex. Clinically, issues such as cataract surgery, correcting the refractive error, quality of life, falls, visual impairment and eye care for dementia have been addressed. Summary: Many visual changes occur across dementias, are controversial, often based on limited patient numbers, and no single feature can be regarded as diagnostic of any specific dementia. Nevertheless, visual hallucinations may be more characteristic of dementia with Lewy bodies and Parkinson's disease dementia than Alzheimer's disease or frontotemporal dementia. Differences in saccadic eye movement dysfunction may also help to distinguish Alzheimer's disease from frontotemporal dementia and Parkinson's disease dementia from dementia with Lewy bodies. Eye care professionals need to keep informed of the growing literature in vision/dementia, be attentive to signs and symptoms suggestive of cognitive impairment, and be able to adapt their practice and clinical interventions to best serve patients with dementia
- β¦